Uses
ChemicalBook > CAS DataBase List > Infigratinib

Infigratinib

Uses
Product Name
Infigratinib
CAS No.
872511-34-7
Chemical Name
Infigratinib
Synonyms
BGJ-398;Infligratinib;BGJ;CS-218;BGJ 398;NVP-BGJ398;Infigratinib;Transcrocetinate;NVP-BGJ398, >=98%;BGJ398 (NVP-BGJ398)
CBNumber
CB52589643
Molecular Formula
C26H31Cl2N7O3
Formula Weight
560.48
MOL File
872511-34-7.mol
More
Less

Infigratinib Property

Melting point:
>211°C (dec.)
Boiling point:
747.9±60.0 °C(Predicted)
Density 
1.354
storage temp. 
-20°C
solubility 
Soluble in DMSO (up to 5 mg/ml)
form 
White solid.
pka
11.02±0.70(Predicted)
color 
White
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months.
InChIKey
QADPYRIHXKWUSV-UHFFFAOYSA-N
SMILES
N(C1C=C(NC2=CC=C(N3CCN(CC)CC3)C=C2)N=CN=1)(C)C(NC1=C(Cl)C(OC)=CC(OC)=C1Cl)=O
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P321Specific treatment (see … on this label).

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

P362Take off contaminated clothing and wash before reuse.

P403+P233Store in a well-ventilated place. Keep container tightly closed.

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
19157
Product name
BGJ398
Purity
≥98%
Packaging
1mg
Price
$62
Updated
2024/03/01
Cayman Chemical
Product number
19157
Product name
BGJ398
Purity
≥98%
Packaging
5mg
Price
$120
Updated
2024/03/01
Cayman Chemical
Product number
19157
Product name
BGJ398
Purity
≥98%
Packaging
10mg
Price
$191
Updated
2024/03/01
Cayman Chemical
Product number
19157
Product name
BGJ398
Purity
≥98%
Packaging
25mg
Price
$313
Updated
2024/03/01
TRC
Product number
B367000
Product name
BGJ398
Packaging
200mg
Price
$425
Updated
2021/12/16
More
Less

Infigratinib Chemical Properties,Usage,Production

Uses

BGJ 398 is a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase.

Description

NVP-BGJ398 (872511-34-7) is a potent and selective pan-FGFR inhibitor (IC50?= 0.9nM, 1.4 nM, 1.0 nM, and 60 nM for FGFR1,2,3,4 respectively).1? It has also been used in a mouse model of Achondroplasia (most common form of dwarfism) to correct pathological hallmarks of this condition.

Uses

BGJ 398 is a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase.

Definition

ChEBI: BGJ-398 is a member of the class of phenylureas that is urea in which a hydrogen attached to one of the nitrogens is replaced by a 2,6-dichloro-3,5-dimethoxyphenyl group, while the hydrogens attached to the other nitrogen are replaced by a methyl group and a 6-{[4-(4-ethylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl group. It is a potent and selective fibroblast growth factor receptor inhibitor. It has a role as a fibroblast growth factor receptor antagonist and an antineoplastic agent. It is an aminopyrimidine, a N-arylpiperazine, a N-alkylpiperazine, a dichlorobenzene and a member of phenylureas.

Indications

Infigratinib is approved by the USFDA for the treatment of previously treated patients with advanced or metastatic cholangiocarcinoma carrying FGFR2 fusion or rearrangement. Its inhibitory effect on FGFR helps reduce the proliferation of tumor cells, especially for cholangiocarcinoma patients with abnormal activation of the FGFR pathway. It is used as an oral drug, which provides convenience for patients.

brand name

Truseltiq

General Description

Class: receptor tyrosine kinase; Treatment: cholangiocarcinoma; Other name: NVP-BGJ398; Elimination half-life = 34 h; Protein binding = 96.8%

Mechanism of action

Infigratinib works at the biochemical and cellular levels by highly selectively inhibiting the activity of FGFR1, FGFR2, FGFR3, and FGFR4. Activation of the FGFR pathway is associated with the proliferation of malignant cancer cells, therefore, inhibition of FGFR-specific kinases can effectively reduce tumor cell proliferation.

Side effects

Side effects of infigratinib may include stomatitis, fatigue, decreased appetite, high blood pressure, and elevated liver enzyme levels.

Synthesis

Infigratinib was synthesized in a modular and polymeric manner by combining three building blocks. Piperidine-substituted aniline 32.4 was prepared by SNAr reaction of piperidine 32.1 and bromonitrobenzene 32.2 at 80°C followed by nitro reduction (Figure 1a). 2,6-Dichloro-3,5-dimethoxyaniline (32.6) was obtained from commercially available 3,5-dimethoxyaniline (32.5) in three steps (acylation, chlorination, and hydrolysis) (Figure 1b), and 6-chloro-N-methylpyrimidin-4-amine (32.8) was prepared by SNAr reaction of dichloropyrimidine 32.7 with methylamine (Figure 1c).

Aniline 32.4 and chloropyrimidine 32.8 were SNAr reacted to generate arylmethylamine 32.9, thereby assembling Infigratinib (Figure 2). The aniline derivative 32.6 was converted in situ to the corresponding isocyanate and combined with 32.9 to form a urea bond, completing the synthesis of Infigratinib.

target

FGFR1

IC 50

FGFR1~4 IC50 = 0.9, 1.4, 1.0, and 60 nM; VEGFR2 IC50 = 180 nM

References

[1] Discovery of 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-{[4-(4-ethyl-1-piperazinyl)phenyl]amino}-4-pyrimidinyl)-1-methylurea (NVP-BGJ398), a Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
[2] DAVIDE KOMLA-EBRI. Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model.[J]. The Journal of clinical investigation, 2016: 1871-1884. DOI:10.1172/jci83926

Infigratinib Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Infigratinib Suppliers

AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
ApexBio Technology LLC
Tel
+1-832-696-8203
Fax
+1-832-641-3177
Email
info@apexbt.com
Country
United States
ProdList
477
Advantage
60
Target molecule Corp.
Tel
857-239-0968
Fax
857-239-8801
Email
service1@targetmol.com
Country
United States
ProdList
2559
Advantage
60
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Cckinase, Inc.
Tel
+1 (732)236-3202
Email
sales@cckinase.com
Country
United States
ProdList
2738
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19552
Advantage
58
Alchem Pharmtech,Inc.
Tel
8485655694
Email
sales@alchempharmtech.com
Country
United States
ProdList
63687
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
NE Scientific
Tel
--
Fax
--
Country
United States
ProdList
5030
Advantage
55
Focus Biomolecules
Tel
--
Fax
--
Email
sales@focusbiomolecules.com
Country
United States
ProdList
1284
Advantage
58
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
Creative Enzymes
Tel
--
Fax
--
Email
info@creative-enzymes.com
Country
United States
ProdList
6057
Advantage
58
Combi-Blocks Inc.
Tel
--
Fax
--
Email
sales@combi-blocks.com
Country
United States
ProdList
6618
Advantage
69
Matrix Scientific
Tel
--
Fax
--
Email
sales@matrixscientific.com
Country
United States
ProdList
6632
Advantage
80
Santa Cruz Biotechnology, Inc.
Tel
--
Fax
--
Email
scbt@scbt.com
Country
United States
ProdList
3597
Advantage
60
LKT Laboratories, Inc.
Tel
--
Fax
--
Email
info@lktlabs.com
Country
United States
ProdList
2164
Advantage
64
ChemieTek
Tel
--
Fax
--
Email
info@chemietek.com
Country
United States
ProdList
219
Advantage
50
AK Scientific, Inc.
Tel
--
Fax
--
Email
sales@aksci.com
Country
United States
ProdList
6347
Advantage
65
More
Less

View Lastest Price from Infigratinib manufacturers

Zibo Hangyu Biotechnology Development Co., Ltd
Product
Infigratinib 872511-34-7
Price
US $0.00/Bag
Min. Order
1Bag
Purity
>99%
Supply Ability
1kg
Release date
2025-06-29
shandong perfect biotechnology co.ltd
Product
Infigratinib (BGJ398) 872511-34-7
Price
US $0.00/g
Min. Order
1g
Purity
98% HPLC
Supply Ability
1kg
Release date
2023-08-02
Career Henan Chemical Co
Product
3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea 872511-34-7
Price
US $2.00/KG
Min. Order
1g
Purity
98%min
Supply Ability
ask
Release date
2020-01-08

872511-34-7, InfigratinibRelated Search:


  • 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea
  • BGJ 398
  • BGJ-398
  • BGJ398 (NVP-BGJ398)
  • NVP-BGJ398
  • 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea NVP-BGJ398
  • NVP-BGJ398 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea
  • Urea, N'-(2,6-dichloro-3,5-dimethoxyphenyl)-N-[6-[[4-(4-ethyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]-N-methyl-, methanesulfonate
  • Urea, N'-(2,6-dichloro-3,5-dimethoxyphenyl)-N-[6-[[4-(4-ethyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]-N-methyl-
  • NVP-BGJ398, >=98%
  • NVP-BGJ398 (Infigratinib)
  • CS-218
  • NVP-BGJ398; BGJ398; BGJ-398;INFIGRATINIB;BGJ 398
  • BGJ
  • BGJ-398 phosphate,NVP-BGJ398 phosphate,Infigratinib phosphate
  • Transcrocetinate
  • BGJ398 (NVP-BGJ398);BGJ-398; BGJ 398; NVP BGJ398
  • 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-
  • NVP-BGJ398(BGJ-398,Infigratinib)
  • Infligratinib
  • NVP-BGJ398(BGJ-398)
  • Infigratinib (BGJ-398)
  • Infigratinib free base
  • 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-[6-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-methylurea
  • Apoptosis,Infigratinib,Fibroblast growth factor receptor,BGJ398,inhibit,Inhibitor,BGJ 398,FGFR
  • Infigratinib
  • 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]-1-methylurea
  • Infigratinib, 10 mM in DMSO
  • Infigratinib/BGJ398 (NVP-BGJ398)
  • 872511-34-7
  • 72511-34-7
  • C26H31Cl2N7O3
  • Inhibitors
  • Inhibitor
  • API